Generic placeholder image

Current Drug Safety


ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Case Report

Imputability of Azathioprine in the Occurrence of Chronic Myeloid Leukemia in Crohn's Disease: An Exceptional Case Report

Author(s): Yosra Zaimi*, Chayma Bouksir, Shema Ayadi, Myriam Ayari and Feryal Letaief Ksontini

Volume 18, Issue 4, 2023

Published on: 16 September, 2022

Page: [596 - 598] Pages: 3

DOI: 10.2174/1574886317666220608152823

Price: $65


Background: Patients with Cohn’s disease (CD) treated with thiopurines are at an increased risk of developing cancer. Leukemias are less frequent than other hematopoietic tumors and the development of Chronic myeloid leukemia (CML) after immunosuppression has not been proven.

Case Report: We describe the case of a 61-year-old female who developed a CML after 8 years of treatment with azathioprine (AZA) for ileal Crohn’s disease associated with a duodenal localization. We reviewed the current evidence on the interactions between CD, CML and AZA as well as the potential underlying mechanisms of leukemia in AZA-treated patients.

Conclusion: We concluded that the pathogenesis of CML is multifactorial in CD. The nature of the association between AZA and CML in CD patients warrants further investigation.

Keywords: Crohn’s disease, thiopurines, immunomodulators, AML, NM, CML.

Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn’s disease in a population-based cohort from cardiff (1986-2003): A study of changes in medical treatment and surgical resectionrates. Gut 2010; 59(9): 1200-6.
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127(20): 2391-405.
[] [PMID: 27069254]
Wei J, Feng J. Signaling pathways associated with inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov 2010; 4(2): 105-17.
[] [PMID: 20001899]
Martelli AM, Tazzari PL, Evangelisti C, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: From bench to bedside. Curr Med Chem 2007; 14(19): 2009-23.
[] [PMID: 17691943]
Karran P, Attard N. Thiopurines in current medical practice: Molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 2008; 8(1): 24-36.
[] [PMID: 18097462]
Caspi O, Polliack A, Klar R, Ben-Yehuda D. The association of inflammatory bowel disease and leukemia--coincidence or not? Leuk Lymphoma 1995; 17(3-4): 255-62.
[] [PMID: 8580794]
Katsanos KH, Vagias I, Tsianos VE, Vassou A, Tsianos EV. Chronic myelogenous leukemia in ulcerative colitis. Ann Gastroenterol 2011; 24(1): 64.
[PMID: 24714265]
Askling J, Brandt L, Lapidus A, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005; 54(5): 617-22.
[] [PMID: 15831904]
Makarem JA, Otrock ZK, Sharara AI, Taher AT. Crohn’s disease in leukemia: Report of a case, with a review of the literature. Dig Dis Sci 2005; 50(10): 1950-0.
[] [PMID: 16187202]
Peng Y, Thomas AS, Wei D, Tan D, Wang Y. An aggressive approach toward a case of refractory ulcerative colitis with uncertain etiology in the context of chronic myeloid leukemia. Inflamm Bowel Dis 2020; 26(4): e26-7.
[] [PMID: 32016290]
Kallel L, Naijaa N, Fekih M, et al. Acute myeloid leukemia after one month of azathioprine therapy in a Crohn’s disease patient. J Clin Gastroenterol 2010; 44(9): 660.
[] [PMID: 20216428]
Mullier F, Rahier JF, Maignen F, et al. A case of therapy-related myeloid neoplasm in a patient with Crohn’s disease treated with azathioprine. Acta Haematol 2012; 128(1): 1-6.
[] [PMID: 22572218]
Pelloso LAF, Campos MGV, Nascimento M, Silva MRR, Pestana JOM, Chauffaille M de LLF. Chronic myeloid leukemia following kidney transplantation. Leuk Res 2005; 29(3): 353-5.
[] [PMID: 15661273]

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy